Physician profile
Letisha A Sneed
NPI 1750385027
$894.01
in general payments reported to CMS, 2019-2025
16 companies · $261 in 2025
The $261 reported for 2025 was more than what 81% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.29 · 2020: $138 · 2021: $62.26 · 2022: $59.90 · 2023: $171 · 2024: $165 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $122.09 | 2024-2025 | Azstarys |
| Palette Life Sciences, INC. | $118.75 | 2020 | |
| Sanofi Pasteur INC. | $101.33 | 2022-2023 | |
| Collegium Pharmaceutical, INC. | $93.38 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $83.42 | 2020-2024 | Gardasil 9, Gardasil, Vaxneuvance |
| Cranial Technologies, INC | $66.48 | 2021-2025 | Doc Band |
| Alk-Abello, INC | $64.72 | 2023 | Ragwitek, Odactra, Grastek |
| Ironshore Pharmaceuticals INC. | $44.02 | 2022-2024 | |
| Tris Pharma INC | $32.81 | 2019-2022 | |
| Acadia Pharmaceuticals INC | $32.48 | 2024 | Daybue |
| Xeris Pharmaceuticals, INC. | $30.85 | 2025 | Keveyis |
| Takeda Pharmaceuticals U.S.A., INC. | $23.49 | 2025 | Eohilia |
| Lnhc, INC | $21.95 | 2025 | Zelsuvmi |
| Pfizer INC. | $21.05 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $19.48 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $17.71 | 2025 | Kristalose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Letisha Sneed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.